Combinations containing a 4-acylaminopyridine derivative
US7998971B2 · kind B2 · utility
69Cited by
560References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2007 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Feb 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system. The disclosure includes compositions and methods based on use of a 4-acylaminopyridine derivative in combination with one or more other neurogenic agents. One 4-acylaminopyridine derivative is MKC-231.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.